NK cell killing via the death receptor pathway involves the binding of Fas Ligand (FasL) or TRAIL to their cognate receptors on tumour surfaces, Fas and Death Receptor (DR)4/DR5, respectively. The gene discussed is FASLG; the disease is neoplasm.